John Y. Dong

900 total citations
16 papers, 741 citations indexed

About

John Y. Dong is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, John Y. Dong has authored 16 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in John Y. Dong's work include Viral Infections and Vectors (10 papers), Viral Infections and Outbreaks Research (9 papers) and Mosquito-borne diseases and control (6 papers). John Y. Dong is often cited by papers focused on Viral Infections and Vectors (10 papers), Viral Infections and Outbreaks Research (9 papers) and Mosquito-borne diseases and control (6 papers). John Y. Dong collaborates with scholars based in United States, Australia and Poland. John Y. Dong's co-authors include Jan Woraratanadharm, Danher Wang, Min Luo, David H. Holman, William D. Pratt, Nicholas U. Raja, Kanakatte Raviprakash, Kevin R. Porter, Adam Penn‐Nicholson and Kelly L. Warfield and has published in prestigious journals such as Journal of Virology, Virology and Vaccine.

In The Last Decade

John Y. Dong

16 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Y. Dong United States 13 516 275 189 136 74 16 741
Michelle Meyer United States 14 455 0.9× 222 0.8× 140 0.7× 186 1.4× 50 0.7× 21 726
Jan Woraratanadharm United States 13 488 0.9× 232 0.8× 258 1.4× 338 2.5× 234 3.2× 18 1.1k
Andrew I. Flyak United States 20 756 1.5× 123 0.4× 590 3.1× 187 1.4× 84 1.1× 30 1.4k
W Kell United States 9 454 0.9× 115 0.4× 157 0.8× 52 0.4× 33 0.4× 9 664
Kirsten Kabsch Germany 8 301 0.6× 35 0.1× 304 1.6× 136 1.0× 86 1.2× 9 615
Isabel Gallego Spain 16 191 0.4× 74 0.3× 234 1.2× 235 1.7× 176 2.4× 35 762
Kathleen A. Cashman United States 16 575 1.1× 42 0.2× 249 1.3× 137 1.0× 52 0.7× 21 770
Vladislav V. Mokhonov Russia 12 301 0.6× 274 1.0× 91 0.5× 144 1.1× 58 0.8× 25 640
Karen Martins United States 14 344 0.7× 139 0.5× 147 0.8× 98 0.7× 22 0.3× 22 589
André M. Vale Brazil 17 197 0.4× 430 1.6× 356 1.9× 125 0.9× 28 0.4× 45 890

Countries citing papers authored by John Y. Dong

Since Specialization
Citations

This map shows the geographic impact of John Y. Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Y. Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Y. Dong more than expected).

Fields of papers citing papers by John Y. Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Y. Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Y. Dong. The network helps show where John Y. Dong may publish in the future.

Co-authorship network of co-authors of John Y. Dong

This figure shows the co-authorship network connecting the top 25 collaborators of John Y. Dong. A scholar is included among the top collaborators of John Y. Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Y. Dong. John Y. Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Danher, Andreas Suhrbier, Adam Penn‐Nicholson, et al.. (2011). A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. Vaccine. 29(15). 2803–2809. 98 indexed citations
2.
Pratt, William D., Danher Wang, Donald K. Nichols, et al.. (2010). Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector. Clinical and Vaccine Immunology. 17(4). 572–581. 80 indexed citations
3.
Holman, David H., Adam Penn‐Nicholson, Danher Wang, et al.. (2009). A Complex Adenovirus-Vectored Vaccine against Rift Valley Fever Virus Protects Mice against Lethal Infection in the Presence of Preexisting Vector Immunity. Clinical and Vaccine Immunology. 16(11). 1624–1632. 34 indexed citations
4.
Swenson, Dana L., Danher Wang, Min Luo, et al.. (2008). Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections. Clinical and Vaccine Immunology. 15(3). 460–467. 102 indexed citations
5.
Holman, David H., Danher Wang, Nicholas U. Raja, et al.. (2008). Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine. 26(21). 2627–2639. 36 indexed citations
6.
Raviprakash, Kanakatte, Danher Wang, Dan Ewing, et al.. (2008). A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus. Journal of Virology. 82(14). 6927–6934. 94 indexed citations
7.
Woraratanadharm, Jan, Semyon Rubinchik, Hong Yu, & John Y. Dong. (2007). Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression. BMC Biotechnology. 7(1). 9–9. 6 indexed citations
8.
Luo, Min, Danher Wang, Jason A. Wicker, et al.. (2007). Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses. Clinical and Vaccine Immunology. 14(9). 1117–1126. 25 indexed citations
9.
Raja, Nicholas U., David H. Holman, Kanakatte Raviprakash, et al.. (2007). INDUCTION OF BIVALENT IMMUNE RESPONSES BY EXPRESSION OF DENGUE VIRUS TYPE 1 AND TYPE 2 ANTIGENS FROM A SINGLE COMPLEX ADENOVIRAL VECTOR. American Journal of Tropical Medicine and Hygiene. 76(4). 743–751. 20 indexed citations
10.
Wang, Danher, Michael Hevey, Laure Juompan, et al.. (2006). Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges. Virology. 353(2). 324–332. 31 indexed citations
11.
Norris, James S., Alicja Bielawska, Terry A. Day, et al.. (2006). Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Therapy. 13(12). 1045–1051. 56 indexed citations
12.
Wang, Danher, Nicholas U. Raja, Charles M. Trubey, et al.. (2006). Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus. Journal of Virology. 80(6). 2738–2746. 34 indexed citations
13.
Holman, David H., Danher Wang, Kanakatte Raviprakash, et al.. (2006). Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes. Clinical and Vaccine Immunology. 14(2). 182–189. 41 indexed citations
14.
Dong, John Y. & Jan Woraratanadharm. (2005). Gene Therapy Vector Design Strategies for the Treatment of Cancer. Future Oncology. 1(3). 361–373. 12 indexed citations
15.
16.
Markiewicz, Margaret, Edwin A. Smith, S Rubinchik, et al.. (2004). The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.. PubMed. 22(3 Suppl 33). S31–4. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Meyer Breakdown of academic impact, for papers by Jan Woraratanadharm Breakdown of academic impact, for papers by Andrew I. Flyak Breakdown of academic impact, for papers by W Kell Breakdown of academic impact, for papers by Kirsten Kabsch Breakdown of academic impact, for papers by Isabel Gallego Breakdown of academic impact, for papers by Kathleen A. Cashman Breakdown of academic impact, for papers by Vladislav V. Mokhonov Breakdown of academic impact, for papers by Karen Martins Breakdown of academic impact, for papers by André M. Vale
Rankless by CCL
2026